Biochemistry
Angiopoietins have the potential for treating several human diseases
Published in Diabetes Week, June 30th, 2003
"Angiopoietins are a recently discovered family of growth factors which act on endothelial cells via Tie receptors. They are widely expressed and have essential roles in regulating vascular growth, development, maturation and permeability. Disturbances in microvascular regulation play an important part in a number of diseases prominent in the developed world including diabetes, ischemic heart disease and cancer," scientists in England report.
"It is the interplay between angiopoietins and other factors including vascular endothelial growth factor (VEGF) which determines endothelial...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Diabetes Week
Source: Diabetes Week (2003-06-30)
More Articles from Diabetes Week
- Heart Disease Risk Factor
Stricter blood pressure guidelines urged for diabetic patients - Type 2 Diabetes Therapy
Pioglitazone improves glycemic control and lipid profiles in type 2 diabetes - Diabetes Genomics and Genetics
Interleukin-6 promoter polymorphism associated with type 2 diabetes - Insulin
Poloxamer gel developed for transdermal delivery of insulin - Insulin
Slow-acting insulin analog O346 provides release over 48 hours in dogs - Type 2 Diabetes Therapy
Compliance with practice guidelines for type 2 diabetes needs improvement - More from this issue of Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
